1-methyl-1,2-diphenylethylamine monohydrochloride has been researched along with Cerebral Ischemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schachter, SC; Tarsy, D | 1 |
1 review(s) available for 1-methyl-1,2-diphenylethylamine monohydrochloride and Cerebral Ischemia
| Article | Year |
|---|---|
Remacemide: current status and clinical applications.
Topics: Acetamides; Animals; Anticonvulsants; Brain Ischemia; Epilepsy; Excitatory Amino Acid Antagonists; Humans; Huntington Disease; Intraoperative Complications; Neuroprotective Agents; Parkinson Disease; Phenethylamines; Receptors, N-Methyl-D-Aspartate | 2000 |